D
C. Chen et al.
Special Topic
Synthesis
1H NMR (400 MHz, CDCl3): = 7.60 (d, J = 2.2 Hz, 1 H), 7.57–7.56 (m, 1
H), 4.47 (d, J = 8.6 Hz, 1 H), 7.40–7.35 (m, 5 H), 7.32–7.28 (m, 4 H),
7.22–7.28 (m, 2 H), 6.76 (dd, J = 2.2, 0.9 Hz, 1 H), 4.02 (q, J = 6.8 Hz, 1
H), 3.62 (d, J = 13.8 Hz, 2 H), 3.48 (d, J = 13.8 Hz, 2 H), 1.48 (d, J = 6.9
Hz, 3 H).
13C NMR (101 MHz, CDCl3): = 157.8, 147.1, 139.6, 137.1, 134.7,
129.0, 128.1, 126.9, 120.8, 54.2, 29.7, 22.2, 13.2.
HRMS (ESI+): m/z calcd for C22H25N2 [M + H]+: 317.2012; found:
317.2013.
13C NMR (101 MHz, CDCl3): = 154.0, 145.0, 140.5, 137.4, 128.7,
128.2, 126.7, 125.0, 120.0, 110.7, 106.7, 56.2, 53.6, 14.3.
HRMS (ESI+): m/z calcd for C24H24NO [M + H]+: 342.1852; found:
342.1853.
(S)-N,N-Dibenzyl-1-phenylpropan-1-amine (3k)
Prepared according to the general procedure from trans--methylsty-
rene (47 mg, 0.40 mmol) and O-benzoyl-N,N-dibenzylhydroxylamine
(380 mg, 1.20 mmol). The product was isolated as a colorless oil (78
mg, 60%) with 92% ee. Enantiomeric excess was determined by SFC
with a Lux Cellulose-4 column (CO2/MeOH, 3 mL/min, 220 nm);
tR = 1.81, 2.41 min.
(S)-1-(Benzo[b]thiophen-5-yl)-N,N-dibenzylethan-1-amine (3h)
Prepared according to the general procedure from 5-vinylben-
zo[b]thiophene (64 mg, 0.40 mmol) and O-benzoyl-N,N-dibenzylhy-
droxylamine (380 mg, 1.20 mmol). After column chromatography,
impurity could be washed off by acid/base extraction. The product
was isolated as a colorless oil (122 mg, 85%) with 91% ee. Enantiomer-
ic excess was determined by SFC with a Lux Cellulose-3 column
(CO2/MeOH, 3 mL/min, 220 nm); tR = 5.50, 8.19 min; []D20 –69.4
(c 1.30, MeOH).
1H NMR (400 MHz, CDCl3): = 8.88 (d, J = 4.2, 1.7 Hz, 1 H), 8.14 (d,
J = 8.0 Hz, 1 H), 8.09 (d, J = 8.8 Hz, 1 H), 7.88 (dd, J = 8.8, J = 1.9 Hz, 1
H), 7.72 (s, 1 H), 7.40–7.37 (m, 5 H), 7.33–7.29 (m, 4 H), 7.24–7.20 (m,
2 H), 4.1 (q, J = 6.8 Hz, 1 H), 3.58 (d, J = 3.5 Hz, 4 H), 1.54 (d, J = 6.8 Hz,
3 H).
1H NMR spectrum was identical with that reported.2
(S)-1-(1-Phenylethyl)piperidine (4b)
Prepared according to the general procedure from styrene (42 mg,
0.40 mmol) and piperidin-1-yl benzoate (246 mg, 1.20 mmol). The
product was isolated as a colorless oil (25 mg, 33%) with 94% ee. Enan-
tiomeric excess was determined by chiral GC with a Supelco beta-
DEX325 column (30 m × 0.25 mm × 0.25 m), He 1.0 mL/min, 100 °C;
tR = 23.05, 23.32 min.
1H NMR spectrum was identical with that reported.3
(S)-4-(1-Phenylethyl)morpholine (4c)
13C NMR (101 MHz, CDCl3): = 150.0, 147.7, 141.8, 140.1, 136.0,
130.9, 129.0, 128.7, 128.3, 126.9, 125.6, 121.0, 55.9, 53.6, 12.5.
HRMS (ESI+): m/z calcd for C24H24NS [M + H]+: 358.1624; found:
358.1623.
Prepared according to the general procedure from styrene (42 mg,
0.40 mmol) and morpholino benzoate (248 mg, 1.20 mmol). The
product was isolated as a colorless oil (45 mg, 59%) with 84% ee. Enan-
tiomeric excess was determined by chiral GC with a Supelco beta-
DEX325 column (30 m × 0.25 mm × 0.25 m), He 1.0 mL/min, 120 °C;
tR = 32.20, 32.72 min.
(S)-N,N-Dibenzyl-1-(quinolin-6-yl)ethan-1-amine (3i)
1H NMR spectrum was identical with that reported.3
Prepared according to the general procedure from 6-vinylquinoline
(62 mg, 0.40 mmol) and O-benzoyl-N,N-dibenzylhydroxylamine (380
mg, 1.20 mmol). The product was isolated as a colorless oil (59 mg,
42%) with 57% ee. Enantiomeric excess was determined by SFC with a
Lux Cellulose-4 column (CO2/MeOH, 3 mL/min, 220 nm); tR = 4.69,
5.44 min; []D20 +8.0 (c 0.30, MeOH).
1H NMR (400 MHz, CDCl3): = 8.88 (dd, J = 4.2, 1.8 Hz, 1 H), 8.15–8.12
(m, 1 H), 8.09 (d, J = 9.2 Hz, 1 H), 7.88 (dd, J = 8.8, 2.0 Hz, 1 H), 7.72 (br,
1 H), 7.39–7.29 (m, 9 H), 7.24–7.20 (m, 2 H), 4.10 (q, J = 6.9 Hz, 1 H),
3.58 (q, J = 3.60 Hz, 4 H), 1.54 (d, J = 6.8 Hz, 3 H).
(S)-1-(1-Phenylethyl)azepane (4d)
Prepared according to the general procedure from styrene (42 mg,
0.40 mmol) and azepan-1-yl benzoate (263 mg, 1.20 mmol). The
product was isolated as a colorless oil (34 mg, 42%) with 84% ee. Enan-
tiomeric excess was determined by chiral GC with a Supelco beta-
DEX325 column (30 m × 0.25 mm × 0.25 m), He 1.0 mL/min, 100 °C;
tR = 31.85, 32.37 min.
1H NMR spectrum was identical with that reported.3
13C NMR (101 MHz, CDCl3): = 149.0, 146.7, 140.8, 139.1, 135.0,
129.9, 128.0, 127.7, 127.2, 126.8, 125.9, 124.5, 120.0 54.8, 52.6, 28.7.
HRMS (ESI+): m/z calcd for C25H25N2 [M + H]+: 353.2012; found:
353.2013.
Funding Information
We thank Boehringer Ingelheim Pharmaceuticals for financial sup-
port.()
(S)-N,N-Dibenzyl-1-(2-methylpyridin-3-yl)ethan-1-amine (3j)
Prepared according to the general procedure A from 2-methyl-3-vin-
ylpyridine (48 mg, 0.40 mmol) and O-benzoyl-N,N-dibenzylhydroxyl-
amine (380 mg, 1.20 mmol). The product was isolated as a colorless
oil (41 mg, 32%) with 49% ee. Enantiomeric excess was determined by
SFC with a Lux Cellulose-4 column (CO2/MeOH, 3 mL/min, 220 nm);
tR = 2.29, 2.82 min; []D20 +103.3 (c 0.50, MeOH).
Acknowledgment
We thank Scott Pennino and Lifen Wu of Boehringer Ingelheim Phar-
maceuticals for HRMS analysis.
1H NMR (400 MHz, CDCl3): = 8.35 (dd, J = 4.8, 1.6 Hz, 1 H), 7.73 (dd,
J = 7.8, 1.5 Hz, 1 H), 7.29–7.21 (m, 10 H), 7.09 (dd, J = 7.8, 4.8 Hz, 1 H),
4.09 (q, J = 6.8 Hz, 1 H), 3.58 (q, J = 13.8 Hz, 4 H), 2.35 (s, 3 H), 1.40 (d,
J = 6.8 Hz, 3 H).
Supporting Information
Supporting information for this article is available online at
S
u
p
p
orit
n
gInformati
o
n
S
u
p
p
orit
n
gInformati
o
n
© 2020. Thieme. All rights reserved. Synthesis 2020, 52, A–E